This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Health and Human Services Secretary Robert F. Kennedy Jr. has railed against what he sees as a “revolving door” between workers at drug companies and the Food and Drug Administration. But his department’s actions now seem to be causing that door to spin ever faster. Scores of FDA employees are searching for an exit from an agency in turmoil, particularly staff members tasked with reviewing drug applications, according to interviews with former employees and industry re
Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. A federal judge on Thursday ruled against a compounding trade group’s request for a preliminary injunction that would have prevented the Food and Drug Administration from taking action against its members for making copies of semaglutide.
Vect-Horus has announced the appointment of Philippe Masset to the companys board of directors. This contributes to a series of senior leadership appointments which are strategic for Vect-Horus growth. Masset is a senior banking executive with a wealth of experience in investment banking, environmental, social and governance (ESG) topics, sustainable finance, and AI.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up on our reading, but are, otherwise, open to suggestion. Of course, we do hope to hold another listening party, where the rotation will likely include this , this , this , this and this.
Almost five million Pharmacy First consultations were delivered in the first year of the service in England, official data has confirmed. The latest data from the NHS Business Services Authority (NHSBSA) shows that contractors in England submitted claims for 4,941,308 Pharmacy First consultations between February 2024 and January 2025. Of those, more than half (2,735,577) […] The post Almost five million Pharmacy First consultations delivered in first year appeared first on The Pharmacist.
The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines — Haleon, Kenvue, and Boehringer Ingelheim — the equivalent of $12.8 million for engaging in a long-running scheme that favored placement of their products in pharmacies. Known as category management arrangements, this involves using one or more companies allegedly conspiring to ensure their products receive favorable placement in stores.
169
169
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines — Haleon, Kenvue, and Boehringer Ingelheim — the equivalent of $12.8 million for engaging in a long-running scheme that favored placement of their products in pharmacies. Known as category management arrangements, this involves using one or more companies allegedly conspiring to ensure their products receive favorable placement in stores.
ENTOD Pharmaceuticals has announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for a new ophthalmic formulation designed to slow the progression of myopia in children aged 6 to 12 years. This marks the first global regulatory approval for this specific treatment strength in paediatric eye care.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Introduction In todays complex healthcare environment, what does it truly mean to practice Integrated Marketing Communications in pharma? For brands like Keytruda , Humira , and Ozempic , success isnt just about having a powerful product. Its about delivering consistent, engaging messages across a fragmented media landscape. Much like a symphony that requires every instrument to be in sync, pharma marketers must harmonize every touchpoint to resonate with both healthcare professionals and patien
Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug combinations. This elevates the research and platform company to a clinical-stage oncology business, bringing products closer to commercialisation and market access. Mosaic now has exclusive rights to develop its combination products in these trials.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The largest clinical trial investigating a treatment for bronchiectasis has demonstrated a statistically significant reduction in the occurrence of pulmonary exacerbations.Findings from the Phase III ASPEN study of brensocatib could provide future promise for patients, as there are currently no approved treatments for the chronic inflammatory pulmonary disease.
Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral haemorrhagic stroke (ICH). This brings the company closer to rolling out the first approved treatment for the devastating condition. The BIRCH trial, which took place with 16 patients with ICH, met both primary safety and […] The post Successful clinical outcomes for drug treating rare stroke condition appeared first on Pharmafile.
Introduction In the age of digital disruption and evolving patient expectations, does Referral Marketing hold any real value in the pharmaceutical space? Think about this: when a friend recommends a restaurant, youre far more likely to try it. The same psychology applies in healthcare, though with significantly higher stakes. As pharma brands like Ozempic and Dupixent seek to establish deeper connections with prescribers and patients, referral-based strategies are increasingly being tested acros
Todays guest post comes from Scott Hughes, Vice President of Strategy of CareMetx. In this latest analysis from CareMetx, Scott explores how the Inflation Reduction Act (IRA) is reshaping Medicare patients access to critical medications across three high-impact therapeutic areas: immunology, oncology, and endocrinology. Drawing on fresh 2025 plan data, he highlights the emerging barriers faced by patients, the shifting demands on providers, and the strategic implications for drug manufacturers.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Introduction In a rapidly evolving healthcare landscape, how can your Pharma Network stay ahead of the curve? As pharmaceutical brands face an unprecedented wave of digital transformation, strategic innovation, and shifting regulatory landscapes in 2025, optimizing your network has never been more critical. Much like upgrading an outdated GPS for an unknown journey, refreshing your pharma connections will determine whether your brand thrives or struggles in the new era.
The drug, being developed for a rare genetic disorder and currently under review in the U.S., is seen by some investors as critical to Biohaven’s future.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Chemists have confirmed a 67-year-old theory about vitamin B1 by stabilizing a reactive molecule in water - a feat long thought impossible. The discovery not only solves a biochemical mystery, but also opens the door to greener, more efficient ways of making pharmaceuticals. The molecule in question is a carbene, a type of carbon atom with only six valence electrons.
Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for Trodelvy and its cancer cell therapies.
Every April 26th, World Intellectual Property (IP) Day marks a time to celebrate the creativity and innovation that fuel our economy. In 2025, the spotlight is on music—a universal language that connects people, culture and moments. But what if you couldn’t hear it? What if the joy of music was locked away, not by choice, but by biology?
Halozyme claims Merck infringed on patents in developing a subcutaneous form of Keytruda. Elsewhere, Vanda’s challenge to an FDA rejection dragged on, while Sanofi revealed an immune drug setback.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
349 
Let's personalize your content